返回
Inferring recent evolutionary changes in speech sounds
DOI:10.1098/rstb.2020.0198.png)
摘要
En 中文
In this paper, we investigate evolutionarily recent changes in the distributions of speech sounds in the world's languages. In particular, we explore the impact of language contact in the past two millennia on today's distributions. Based on three extensive databases of phonological inventories, we analyse the discrepancies between the distribution of speech sounds of ancient and reconstructed languages, on the one hand, and those in present-day languages, on the other. Furthermore, we analyse the degree to which the diffusion of speech sounds via language contact played a role in these discrepancies. We find evidence for substantive differences between ancient and present-day distributions, as well as for the important role of language contact in shaping these distributions over time. Moreover, our findings suggest that the distributions of speech sounds across geographic macro-areas were homogenized to an observable extent in recent millennia. Our findings suggest that what we call the Implicit Uniformitarian Hypothesis, at least with respect to the composition of phonological inventories, cannot be held uncritically. Linguists who would like to draw inferences about human language based on present-day cross-linguistic distributions must consider their theories in light of even short-term language evolution. This article is part of the theme issue 'Reconstructing prehistoric languages'.
Keyword:
language evolution
phonology
language contact
期刊
IF:
4.7
论文数:
8.7K
被引数:
5.6W
机构
引用论文
Introduction to Optimal Management of Patients With Cardio-KidneyMetabolic Syndrome心血管-肾脏-代谢综合征患者最佳管理导论
Ethanol exposure and burn injury in mice results in unique changes in the fecal metabolome suggesting alterations in the gut- brain axis乙醇暴露和烧伤损伤在 mice 中会导致粪便代谢组的独特变化,提示肠道-大脑轴发生改变
ALCOHOL
IF2.9
EFFICACY AND SAFETY IS MAINTAINED IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RECEIVING PEGCETACOPLAN FOR UP TO 3 YEARS在服用PEGCETACOPLAN治疗长达3年的阵发性夜间血红蛋白尿症成人患者中,疗效和安全性得以维持。

